Zydus Lifesciences Limited

NSEI:ZYDUSLIFE Stock Report

Market Cap: ₹958.9b

Zydus Lifesciences Management

Management criteria checks 3/4

Zydus Lifesciences' CEO is Sharvil Patel, appointed in Apr 2017, has a tenure of 7.58 years. total yearly compensation is ₹300.00M, comprised of 60% salary and 40% bonuses, including company stock and options. directly owns 0.001% of the company’s shares, worth ₹14.10M. The average tenure of the management team and the board of directors is 6.5 years and 7.3 years respectively.

Key information

Sharvil Patel

Chief executive officer

₹300.0m

Total compensation

CEO salary percentage60.0%
CEO tenure7.6yrs
CEO ownership0.001%
Management average tenure6.5yrs
Board average tenure7.3yrs

Recent management updates

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment

Aug 03
Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment

Recent updates

Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 15
Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Just Reported Earnings, And Analysts Cut Their Target Price

Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching

Sep 14
Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market

Aug 30
Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market

Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 14
Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment

Aug 03
Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Jul 19
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 05
Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Jun 20
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

May 25
Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year

Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Mar 18
Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?

Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Feb 28
Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%

Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Feb 12
Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report

Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Dec 27
Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt

Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

Dec 06
Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors

With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Aug 23
With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Jul 17
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Jul 15
We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt

Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Jun 24
Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's

Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Jun 10
Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00

Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

May 21
Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00

Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

Feb 15
Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly

CEO Compensation Analysis

How has Sharvil Patel's remuneration changed compared to Zydus Lifesciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹43b

Jun 30 2024n/an/a

₹42b

Mar 31 2024₹300m₹180m

₹38b

Dec 31 2023n/an/a

₹30b

Sep 30 2023n/an/a

₹28b

Jun 30 2023n/an/a

₹25b

Mar 31 2023₹263m₹180m

₹20b

Dec 31 2022n/an/a

₹21b

Sep 30 2022n/an/a

₹20b

Jun 30 2022n/an/a

₹22b

Mar 31 2022₹200m₹180m

₹22b

Dec 31 2021n/an/a

₹23b

Sep 30 2021n/an/a

₹23b

Jun 30 2021n/an/a

₹23b

Mar 31 2021₹263m₹180m

₹22b

Dec 31 2020n/an/a

₹18b

Sep 30 2020n/an/a

₹17b

Jun 30 2020n/an/a

₹13b

Mar 31 2020₹250m₹247m

₹12b

Dec 31 2019n/an/a

₹12b

Sep 30 2019n/an/a

₹14b

Jun 30 2019n/an/a

₹17b

Mar 31 2019₹250m₹248m

₹18b

Dec 31 2018n/an/a

₹20b

Sep 30 2018n/an/a

₹20b

Jun 30 2018n/an/a

₹21b

Mar 31 2018₹250m₹248m

₹18b

Compensation vs Market: Sharvil's total compensation ($USD3.56M) is above average for companies of similar size in the Indian market ($USD1.09M).

Compensation vs Earnings: Sharvil's compensation has been consistent with company performance over the past year.


CEO

Sharvil Patel (45 yo)

7.6yrs

Tenure

₹300,000,000

Compensation

Dr. Sharvil Pankajbhai Patel has been Managing Director of Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) since April 1, 2017 and previously served as its Joint Managing Director...


Leadership Team

NamePositionTenureCompensationOwnership
Sharvil Patel
MD & Executive Director7.6yrs₹300.00m0.0015%
₹ 14.1m
Ganesh Nayak
COO & Executive Director7.3yrs₹140.00m0.035%
₹ 331.8m
Punit Patel
President & CEO of America1.1yrsno datano data
Nitinkumar Parekh
Chief Financial Officerno data₹54.31mno data
Arvind Bothra
Head of Investor Relationsno datano datano data
Dhaval Soni
Company Secretary & Compliance Officer5.8yrs₹2.09mno data

6.5yrs

Average Tenure

Experienced Management: ZYDUSLIFE's management team is seasoned and experienced (6.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sharvil Patel
MD & Executive Director27.3yrs₹300.00m0.0015%
₹ 14.1m
Ganesh Nayak
COO & Executive Director7.3yrs₹140.00m0.035%
₹ 331.8m
Pankaj Patel
Non-Executive Chairman29.5yrs₹1.20m74.98%
₹ 719.0b
Apurva Diwanji
Independent Director8.5yrs₹4.00mno data
Mukeshbhai Patel
Non-Executive Non-Independent Director27.3yrs₹4.00m0.0012%
₹ 11.1m
Bhadresh Shah
Independent Non-Executive Director5.9yrs₹4.10mno data
Akhil Monappa
Independent Director2yrs₹3.50mno data
Upasana Konidela
Independent Director2yrs₹3.50mno data
Shelina Parikh
Independent Directorless than a yearno data0.00044%
₹ 4.2m

7.3yrs

Average Tenure

56yo

Average Age

Experienced Board: ZYDUSLIFE's board of directors are considered experienced (7.3 years average tenure).